Tetratherix LimitedASX: TTX

Tegenix FDA Review Progress

· Issued by Tetratherix Limited via ASX

Filed with ASX ·

Bone Regeneration FranchiseTegenix FDA Review ProgressTetratherix Limited 2026Anchored by ScienceASX Release6 October 2026ASX:TTXTetratherix Limited (ASX: TTX) advises that it has received a substantive review update from the US Foodand Drug Administration (FDA) on its 510(k) submission for...

View Attachment

6ix hasn’t read this filing yet.

Tetratherix Limited on 6ix

Earlier from Tetratherix

Later from Tetratherix

All Tetratherix news releases